GALNS and mucopolysaccharidosis type 4A: The clinical manifestations and GALNS mutations identified in the 21 MPS IVA patients (15 females, 6 males; mean age 15.5 ± 8.1 years, range 3.4–30.9 years) in this study are shown in Tables 1 and 2.